본문 바로가기
KERD
논문KCI 등재

Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Nuclear receptors are in general ligand-dependent transcription factors that control a variety of mammalian physiologies including development, differentiation, proliferation, and homeostasis. Recent studies have found that two nutrientsensing nuclear receptors, peroxisome proliferator-activated receptor α and farnesoid x receptor, responding to fasting or feeding state, respectively are able to regulate autophagy, an evolutionarily conserved catabolic process involved in lysosomal degradation. In this review, we discuss the role of these nutrient-sensing nuclear receptors in an aspect of transcriptional regulation of autophagy, and how these nuclear receptor-driven transcriptional programs integrate lipophagy, a lipid autophagy with fatty acid oxidation to coordinate hepatic lipid metabolism in the fasted state of the liver.

Abstract

Nuclear receptors are in general ligand-dependent transcription factors that control a variety of mammalian physiologies including development, differentiation, proliferation, and homeostasis. Recent studies have found that two nutrientsensing nuclear receptors, peroxisome proliferator-activated receptor α and farnesoid x receptor, responding to fasting or feeding state, respectively are able to regulate autophagy, an evolutionarily conserved catabolic process involved in lysosomal degradation. In this review, we discuss the role of these nutrient-sensing nuclear receptors in an aspect of transcriptional regulation of autophagy, and how these nuclear receptor-driven transcriptional programs integrate lipophagy, a lipid autophagy with fatty acid oxidation to coordinate hepatic lipid metabolism in the fasted state of the liver.

참고문헌 (59)

  1. Sayiner M, "Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world", Clin Liver Dis, 20, pp.205~214 (2016)
  2. Newton KP, "Prevalence of prediabetes and type 2diabetes in children with nonalcoholic fatty liver disease", JAMA Pediatr, 170, pp.e161971~ (2016)
  3. Wagner M, "Nuclear receptors in liver disease", Hepatology, 53, pp.1023~1034 (2011)
  4. Shulman AI, "Retinoid x receptor heterodimers in the metabolic syndrome", N Engl J Med, 353, pp.604~615 (2005)
  5. Sonoda J, "Nuclear receptors: decoding metabolic disease", FEBS Lett, 582, pp.2~9 (2008)
  6. Shipman KE, "Use of fibrates in the metabolic syndrome: A review", World J Diabetes, 7, pp.74~88 (2016)
  7. Trivedi PJ, "Obeticholic acid for the treatment of primary biliary cirrhosis", Expert Rev Clin Pharmacol, 9, pp.13~26 (2016)
  8. Ding L, "Coordinated actions of FXR and LXR in metabolism: from pathogenesis to pharmacological targets for type 2 diabetes", Int J Endocrinol, 2014, pp.751859~ (2014)
  9. Chawla A, "Nuclear receptors and lipid physiology: opening the X-files", Science, 294, pp.1866~1870 (2001)
  10. Evans RM, "Nuclear Receptors, RXR, and the Big Bang", Cell, 157, pp.255~266 (2014)
  11. Evans RM, "PPARs and the complex journey to obesity", Nat Med, 10, pp.355~361 (2004)
  12. Issemann I, "Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators", Nature, 347, pp.645~650 (1990)
  13. Inagaki T, "Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21", Cell Metab, 5, pp.415~425 (2007)
  14. Owen BM, "FGF21 contributes to neuroendocrine control of female reproduction", Nat Med, 19, pp.1153~1156 (2013)
  15. Zhang Y, "The starvation hormone, fibroblast growth factor-21, extends lifespan in mice", Elife, 1, pp.e00065~ (2012)
  16. Owen BM, "Mangelsdorf DJ. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss", Cell Metab, 20, pp.670~677 (2014)
  17. Talukdar S, "FGF21 regulates sweet and alcohol preference", Cell Metab, 23, pp.344~349 (2016)
  18. Kliewer SA, "Fibroblast growth factor 21: from pharmacology to physiology", Am J Clin Nutr, 91, pp.254~257S (2010)
  19. Bocos C, "Fatty acid activation of peroxisome proliferator-activated receptor (PPAR)", J Steroid Biochem Mol Biol, 53, pp.467~473 (1995)
  20. Chakravarthy MV, "Identification of a physiologically relevant endogenous ligand for PPARalpha in liver", Cell, 138, pp.476~488 (2009)
  21. Lee SS, "Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators", Mol Cell Biol, 15, pp.3012~3022 (1995)
  22. Kersten S, "Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting", J Clin Invest, 103, pp.1489~1498 (1999)
  23. Kalaany NY, "LXRS and FXR: the yin and yang of cholesterol and fat metabolism", Annu Rev Physiol, 68, pp.159~191 (2006)
  24. Chawla A, "Don't know much bileology", Cell, 103, pp.1~4 (2000)
  25. Huang W, "Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration", Science, 312, pp.233~236 (2006)
  26. Ryan KK, "FXR is a molecular target for the effects of vertical sleeve gastrectomy", Nature, 509, pp.183~188 (2014)
  27. Tu H, "FXR, a bile acid receptor and biological sensor", Trends Cardiovasc Med, 10, pp.30~35 (2000)
  28. Zhou H, "Bile acids are nutrient signaling hormones", Steroids, 86, pp.62~68 (2014)
  29. Pellicciari R, "6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity", J Med Chem, 45, pp.3569~3572 (2002)
  30. Maloney PR, "Identification of a chemical tool for the orphan nuclear receptor FXR", J Med Chem, 43, pp.2971~2974 (2000)
  31. Downes M, "A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR", Mol Cell, 11, pp.1079~1092 (2003)
  32. Urizar NL, "A natural product that lowers cholesterol as an antagonist ligand for FXR", Science, 296, pp.1703~1706 (2002)
  33. Ricketts ML, "The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors", Mol Endocrinol, 21, pp.1603~1616 (2007)
  34. Inagaki T, "Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis", Cell Metab, 2, pp.217~225 (2005)
  35. Kir S, "FGF19 as a postprandial, insulinindependent activator of hepatic protein and glycogen synthesis", Science, 331, pp.1621~1624 (2011)
  36. Rinella ME, "Nonalcoholic fatty liver disease: a systematic review", JAMA, 313, pp.2263~2273 (2015)
  37. Bowlus CL, "Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection", Hepat Med, 8, pp.89~95 (2016)
  38. Mizushima N, "Autophagy: renovation of cells and tissues", Cell, 147, pp.728~741 (2011)
  39. Rabinowitz JD, "Autophagy and metabolism", Science, 330, pp.1344~1348 (2010)
  40. Mizushima N, "Methods in mammalian autophagy research", Cell, 140, pp.313~326 (2010)
  41. Gordon PB, "Prelysosomal convergence of autophagic and endocytic pathways", Biochem Biophys Res Commun, 151, pp.40~47 (1988)
  42. Galluzzi L, "Metabolic control of autophagy", Cell, 159, pp.1263~1276 (2014)
  43. Mariño G, "Self-consumption: the interplay of autophagy and apoptosis", Nat Rev Mol Cell Biol, 15, pp.81~94 (2014)
  44. Mizushima N, "Autophagy fights disease through cellular self-digestion", Nature, 451, pp.1069~1075 (2008)
  45. Jin M, "SnapShot: selective autophagy", Cell, 152, pp.368~368 (2013)
  46. Stolz A, "Cargo recognition and trafficking in selective autophagy", Nat Cell Biol, 16, pp.495~501 (2014)
  47. Inoki K, "AMPK and mTOR in cellular energy homeostasis and drug targets", Annu Rev Pharmacol Toxicol, 52, pp.381~400 (2012)
  48. Füllgrabe J, "Transcriptional regulation of mammalian autophagy at a glance", J Cell Sci, 129, pp.3059~3066 (2016)
  49. Füllgrabe J, "The return of the nucleus:transcriptional and epigenetic control of autophagy", Nat Rev Mol Cell Biol, 15, pp.65~74 (2014)
  50. Lee JM, "Nutrient-sensing nuclear receptors coordinate autophagy", Nature, 516, pp.112~115 (2014)
  51. Seok S, "Transcriptional regulation of autophagy by an FXR-CREB axis", Nature, 516, pp.108~111 (2014)
  52. Singh R, "Autophagy regulates lipid metabolism", Nature, 458, pp.1131~1135 (2009)
  53. Singh R, "Lipophagy: connecting autophagy and lipid metabolism", Int J Cell Biol, 2012, pp.282041~ (2012)
  54. Liu K, "Regulation of lipid stores and metabolism by lipophagy", Cell Death Differ, 20, pp.3~11 (2013)
  55. Chennamsetty I, "Farnesoid X receptor represses hepatic human APOA gene expression", J Clin Invest, 121, pp.3724~3734 (2011)
  56. Claudel T, "Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression", Gastroenterology, 125, pp.544~555 (2003)
  57. Sardiello M, "A gene network regulating lysosomal biogenesis and function", Science, 325, pp.473~477 (2009)
  58. Settembre C, "TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop", Nat Cell Biol, 15, pp.647~658 (2013)
  59. Settembre C, "TFEB links autophagy to lysosomal biogenesis", Science, 332, pp.1429~1433 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (10건)